Albumin medicament carrier system
First Claim
Patent Images
1. A therapeutic composition for controlling the release of drugs comprising solid spherules of serum albumin having homogeneously entrapped therein from 5 to 30 percent by weight of the spherule of an organic medicament which is at least 0.01 percent water soluble at 37°
- C., which spherules have been crosslinked by a process selected from the group consisting of;
(a) heating at 110°
to 180°
C. for at least twenty minutes and (b) exposing to at least one chemical crosslinking agent which does not substantially affect the activity of said medicament for sufficient time to crosslink the albumin to a degree equivalent to heating at 110°
to 180°
C. for at least twenty minutes, and when placed in an aqueous medium, said medicament is released in a biphasic manner.
0 Assignments
0 Petitions
Accused Products
Abstract
Solid serum albumin spherules having 5 to 30 percent by weight of an organic medicament homogeneously entrapped therein are disclosed. These spherules are especially suited for intravascular injection into the body wherein the drug is released from the spherule in a biphasic manner having an initial fast release phase followed by a slow release phase.
-
Citations
18 Claims
-
1. A therapeutic composition for controlling the release of drugs comprising solid spherules of serum albumin having homogeneously entrapped therein from 5 to 30 percent by weight of the spherule of an organic medicament which is at least 0.01 percent water soluble at 37°
- C., which spherules have been crosslinked by a process selected from the group consisting of;
(a) heating at 110°
to 180°
C. for at least twenty minutes and (b) exposing to at least one chemical crosslinking agent which does not substantially affect the activity of said medicament for sufficient time to crosslink the albumin to a degree equivalent to heating at 110°
to 180°
C. for at least twenty minutes, and when placed in an aqueous medium, said medicament is released in a biphasic manner. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15)
- C., which spherules have been crosslinked by a process selected from the group consisting of;
-
16. A process for preparing solid serum albumin spherules having a medicament homogeneously entrapped therein comprising injecting an aqueous solution of said albumin having said medicament dispersed therein into an agitated vegetable oil bath containing a lipophilic drying alcohol and a crosslinking agent which does not substantially affect the activity of said medicament selected from the group consisting of glutaraldehyde and formaldehyde.
-
17. A therapeutic composition for controlling the release of drugs comprising solid spherules of serum albumin having homogeneously entrapped therein from 5 to 30 percent by weight of the spherule of an organic medicament which is at least 0.01 percent water soluble at 37°
- C., which spherules have been crosslinked by heating at 110°
to 180°
C. for at least twenty minutes during preparation to crosslink the albumin, and when placed in an aqueous medium, said medicament is released from said spherules in a biphasic manner.
- C., which spherules have been crosslinked by heating at 110°
-
18. A therapeutic composition for controlling the release of drugs comprising solid spherules of serum albumin having homogeneously entrapped therein from 5 to 30 percent by weight of the spherule of an organic medicament which is at least 0.01 percent water soluble at 37°
- C., which spherules have been exposed to at least one chemical crosslinking agent which does not substantially affect the activity of the medicament to crosslink the albumin to a degree equivalent to that achieved by heating at 110°
to 180°
C. for at least twenty minutes, and when placed in an aqueous medium, said medicament is released from said spherules in a biphasic manner.
- C., which spherules have been exposed to at least one chemical crosslinking agent which does not substantially affect the activity of the medicament to crosslink the albumin to a degree equivalent to that achieved by heating at 110°
Specification
-
- Resources
Litigation Campaign Assessment
Thank you for your request. You will receive a custom alert email when the Litigation Campaign Assessment is available.
×
-
Current AssigneeMinnesota Mining and Manufacturing Co (3M Company)
-
Original AssigneeMinnesota Mining and Manufacturing Co (3M Company)
-
InventorsYapel, Anthony F. Jr.
-
Primary Examiner(s)Rose, Shep K.
-
Application NumberUS05/838,355Time in Patent Office550 DaysField of Search424/36, 424/19-22, 252/316US Class Current424/499CPC Class CodesA61K 9/1658 Proteins, e.g. albumin, gel...A61P 35/00 Antineoplastic agentsY10T 428/2989 Microcapsule with solid cor...
